8-week exercise program for older adults with frailty and cognitive impairment

Effectiveness of 8 Week Multicomponent Exercise Program on the General Health and Balance of a Group of Older Adults With Frailty and Cognitive Impairment: a Quasi-experimental Pilot Study

Not applicable Interventional University of Malaga · NCT06440733

This study tests whether an 8-week exercise program can help older adults with frailty and cognitive impairment improve their strength, balance, and overall quality of life.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment17 (estimated)
Ages65 Years and up
SexAll
SponsorUniversity of Malaga Academic / other
Locations1 site (Estación de Cártama, Málaga)
Trial IDNCT06440733 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of an 8-week multicomponent exercise program designed for older adults experiencing frailty and cognitive impairment. Participants will engage in exercise sessions three times a week, focusing on improving physical condition, balance, and overall quality of life. The program includes various activities such as weight training, use of elastic bands, and balance exercises, all tailored to individual capabilities. Assessments will be conducted to measure improvements in physical strength, cognitive state, and emotional well-being.

Who should consider this trial

Good fit: Ideal candidates are adults over 65 years old who exhibit signs of frailty and have the ability to walk, either independently or with assistance.

Not a fit: Patients under 65 years old or those with severe cognitive impairment who cannot participate in the exercise program may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could significantly enhance the quality of life and physical independence of older adults with frailty and cognitive challenges.

How similar studies have performed: Other studies have shown positive outcomes with similar multicomponent exercise interventions in older populations, indicating a promising approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults over 65 years of age.
* People with frailty according to the Short Physical Performance Battery,
* who have the ability to walk (autonomous or with external aids),
* and who obtain a score greater than or equal to 15 in the Lobo Mini Cognitive Examination (MEC-35 of Lobo).
* patients with a resolved hip fracture, with Parkinson's,
* Patients who are committed and motivated to carry out the study, as well as patients who agree to sign the informed consent and the report sheet prior to carrying out the study.

Exclusion Criteria:

* Old Adults under 65 years of age.
* Patients who do not present frailty or the ability to walk (autonomous or with external aids).
* People who obtain a score of less than 15 in the Lobo Mini Cognitive Exam therefore presenting a serious deterioration of the emotional and cognitive state.
* Older adults who are under treatment with tranquilizers or sedatives, non-diuretic hypotensive agents or antidepressants.
* Patients with amyotrophic lateral sclerosis, multiple sclerosis, diabetic neuropathy, severe sensory deficit, and study subjects without motivation or interest in participating in the study.
* Older adults who do not agree to sign the study, will also be excluded from the study. informed consent and the report sheet prior to carrying out the study

Where this trial is running

Estación de Cártama, Málaga

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Old AgeDebilityMulticomponent exercise programFragilityElderlyBalanceQuality of lifeAutonomy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.